Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bevacizumab (avastin) (1 trial)
carboplatin (paraplatin) (1 trial)
carmustine (bicnu) (1 trial)
docetaxel (taxotere) (1 trial)
gefitinib (iressa) (1 trial)
irinotecan (Camptosar) (2 trials)
temozolomide (temodar) (3 trials)
cytarabine (cytosar-u) (1 trial)
gemcitabine (gemzar) (1 trial)
iscar quercus (1 trial)
leucovorin (1 trial)
naltrexone (revia) (1 trial)
procarbazine (matulane) (1 trial)
rituximab (rituxan) (1 trial)
vincristine (oncovin) (1 trial)
Adrenocortical Carcinoma (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Glioma (Phase 2)
Lung Neoplasms (Phase 2)
Trials (8 total)
Trial APIs (15 total)